Apr 8, 2025 | Affordable Care Act, Compliance, Employee Retirement Income Security Act (ERISA), Gag Clause, HIPAA, MedBen Employees, Medicare, Mental Health Parity and Addiction Equity Act (MHPAEA), Regulatory
Employer-sponsored health plans are subject to at least 46 federal laws, most of which apply to self-funded plans, according to a new report from the Congressional Research Service. This ever-expanding regulatory landscape raises employers’ risk of legal and...
Jan 9, 2025 | Affordable Care Act, Compliance, Deadlines, IRS, Medicare, PCORI, Regulatory
The MedBen Compliance team has prepared the 2025 “Self-funded Plan Sponsors Annual Compliance Deadlines” list to help you stay current with all mandatory health plan regulatory requirements. MedBen clients can acquire this valuable reference document...
Apr 12, 2024 | Announcements, Centers for Medicare & Medicaid Services (CMS), Compliance, Medicare, News, Regulatory
On April 1, 2024, the Centers for Medicare & Medicaid Services (CMS) released the Announcement of Calendar Year (CY) 2025 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies (the “Rate Announcement”). The Rate Announcement...
Jan 8, 2024 | Affordable Care Act, Compliance, Deadlines, Forms, IRS, Medicare, PCORI, Reporting
To keep you “in the know” about mandatory regulatory due dates for health plan sponsors, the MedBen Compliance team has again compiled a “Self-funded Plan Sponsors Annual Compliance Deadlines” list. MedBen clients can contact their Account...
Jul 21, 2023 | Diabetes, Medicare, Ozempic, Pharmacy, Prescription, Research, Trulicity, Weight loss
A Kaiser Family Foundation (KFF) analysis of the 10 top-selling prescription drugs under Medicare Part D offers an interesting snapshot of pharmacy spend. The drugs in question comprised less than 1% of all covered drugs in 2021, but made up approximately 22% of total...
Mar 6, 2023 | Access solutions, Cost Savings, MedBen Rx, Medicare, Research, Rx Costs, Savings, Specialty Drugs
Employers pay up to 30 times as much for specialty drugs than Medicare does, new research finds. According to the JAMA Health Forum, for the 10 most commonly used specialty drugs, employer-sponsored insurance (ESI) plans paid prices up to 3,350% higher than Medicare....
